Giant cell arteritis and polymyalgia rheumatica: Diagnostic criteria;Maladie de Horton et pseudopolyarthrite rhizomélique: Critères diagnostiques

Revue de Medecine Interne

Volumn 34, Issue 7, 2013, Pages 403-411

  Marie, I ^a,b  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Arterial ultrasonography; Computerized tomography; Diagnostic criteria; F18 fluorodeoxyglucose positron emission tomography; Giant cell arteritis; Magnetic resonance imaging; Polymyalgia rheumatica; Temporal artery biopsy

Indexed keywords

FERRITIN ANTIBODY;

BLOOD VESSEL BIOPSY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; ECHOGRAPHY; GIANT CELL ARTERITIS; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; POSITRON EMISSION TOMOGRAPHY; RELIABILITY; RESEARCH DIAGNOSTIC CRITERIA; RHEUMATIC POLYMYALGIA; SHORT SURVEY; TEMPORAL ARTERY; VALIDATION STUDY;

ANGIOGRAPHY; ARTHROGRAPHY; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; GIANT CELL ARTERITIS; HUMANS; INFLAMMATION; JOINTS; POLYMYALGIA RHEUMATICA; ULTRASONOGRAPHY, DOPPLER;

EID: 84879601906     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2013.02.025     Document Type: Short Survey

References (82)

1. Horton B.T., Magath T.B., Brown G.E. An undescribed form of arteritis of the temporal vessels. Proc Staff Meet Mayo Clin 1932, 7:700.
2. Assie C., Janvresse A., Plissonnier D., Levesque H., Marie I. Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36patients. Medicine (Baltimore) 2011, 90:40-51.
3. Chatelain D., Duhaut P., Schmidt J., Loire R., Bosshard S., Guernou M., et al. Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss. Ann Rheum Dis 2009, 68:84-88.
4. Gonzalez-Gay M.A., Barros S., Lopez-Diaz M.J., Garcia-Porrua C., Sanchez-Andrade A., Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240patients. Medicine (Baltimore) 2005, 84:269-276.
5. Hervé F., Choussy V., Janvresse A., Cailleux N., Levesque H., Marie I. Aortite inflammatoire et maladie de Horton. À propos du suivi évolutif scanographique prospectif d'une série de 11patients. Rev Med Interne 2006, 27:196-202.
6. Marie I., Proux A., Duhaut P., Primard E., Lahaxe L., Girszyn N., et al. Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48patients. Medicine (Baltimore) 2009, 88:182-192.
7. Salvarani C., Cantini F., Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008, 372:234-245.
8. Assie C., Marie I. Atteintes artérielles des membres supérieurs et inférieurs au cours de la maladie de Horton. Presse Med 2011, 40:151-161.
9. Boutry N., Cotten A. Apport de l'échographie dans les rhumatismes inflammatoires (polyarthrite rhumatoïde, pseudopolyarthrite rhizomélique et spondylarthropathies). Rev Med Interne 2010, 31:29-40.
10. Duhaut P., Ducroix J.P. Maladie de Horton et pseudopolyarthrite rhizomélique. Traité des maladies et syndromes systémiques 2008, 590-618. Flammarion, Paris. 5e éd. L. Guillevin, O. Meyer, J. Sibilia (Eds.).
11. Laborie Y., Berthelot J.M. Pseudopolyarthrites rhizoméliques: mise au point. Rev Med Interne 2002, 23:518-532.
12. Soubrier M., Dubost J.J., Ristori J.M. Pseudopolyarthrite rhizomélique: diagnostic et traitement. Joint Bone Spine 2006, 73:599-605.
13. Hunder G.G., Bloch D.A., Michel B.A., Stevens M.B., Arend W.P., Calabrese L.H., et al. The American College of Rheumatology 1990criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33:1122-1128.
14. Rao J.K., Allen N.B., Pincus T. Limitations of the 1990American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 1998, 129:345-352.
15. Bird H.A., Esselinckx W., Dixon A.S., Mowat A.G., Wood P.H. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979, 38:434-439.
16. Chuang T.Y., Hunder G.G., Ilstrup D.M., Kurland L.T. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982, 97:672-680.
17. Healey L.A. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984, 13:322-328.
18. Jones J.G., Hazleman B.L. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981, 40:1-5.
19. Nobunaga M., Yoshioka K., Yasuda M., Shingu M. Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria. Jpn J Med 1989, 28:452-456.
20. Proven A., Gabriel S.E., O'Fallon W.M., Hunder G.G. Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis. J Rheumatol 1999, 26:1333-1337.
21. Dasgupta B., Cimmino M.A., Kremers H.M., Schmidt W.A., Schirmer M., Salvarani C., et al. 2012Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum 2012, 64:943-954.
22. Kermani T.A., Schmidt J., Crowson C.S., Ytterberg S.R., Hunder G.G., Matteson E.L., et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 2012, 41:866-871.
23. Cantini F., Salvarani C., Olivieri I., Macchioni L., Ranzi A., Niccoli L., et al. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum 2000, 30:17-24.
24. Parikh M., Miller N.R., Lee A.G., Savino P.J., Vacarezza M.N., Cornblath W., et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 2006, 113:1842-1845.
25. Salvarani C., Hunder G.G. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study. Arthritis Rheum 2001, 45:140-145.
26. Duhaut P., Pinède L., Bornet H., Demolombe-Ragué S., Dumontet C., Ninet J., et al. Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l'Artérite à Cellules Géantes. Ann Rheum Dis 1999, 58:335-341.
27. Schmidt J., Duhaut P., Bourgeois A.M., Salle V., Smail A., Chatelain D., et al. Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study. Rheumatology (Oxford) 2009, 48:158-159.
28. Salvarani C., Cantini F., Niccoli L., Macchioni P., Consonni D., Bajocchi G., et al. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum 2005, 53:33-38.
29. Weyand C.M., Fulbright J.W., Evans J.M., Hunder G.G., Goronzy J.J. Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med 1999, 159:577-584.
30. Cailleux N., Lévesque H., Borg J.Y., Clavier E., Courtois H. Maladie de Horton avec atteinte des troncs artériels des membres supérieurs. RÔle pathogène des anticorps anticardiolipine? À propos de deux observations. J Mal Vasc 1992, 17:157-159.
31. Espinoza L.R., Jara L.J., Silveira L.H., Martínez-Osuna P., Zwolinska J.B., Kneer C., et al. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications. Am J Med 1991, 90:474-478.
32. Espinosa G., Tàssies D., Font J., Muñoz-Rodríguez F.J., Cervera R., Ordinas A., et al. Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis. Semin Arthritis Rheum 2001, 31:12-20.
33. Liozon F., Jauberteau-Marchan M.O., Boutros-Toni F., Barrier J.H., Dupond J.L., Roblot P., et al. Anticoprps anticardiolipine et maladie de Horton. Ann Med Interne (Paris) 1995, 146:541-547.
34. Dellaripa P.F., Eisenhauer A.C. Bilateral percutaneous balloon angioplasty of the axillary arteries in a patient with giant cell arteritis and upper extremity ischemic symptoms not responsive to corticosteroids. J Rheumatol 1998, 25:1429-1433.
35. Duhaut P. Anticorps antiβ2-GP1et antiphospholipides dans la maladie de Horton et la PPR: étude multicentrique cas-témoins GRACG. Rev Med Interne 2001, 1:458.
36. Schmidt W.A., Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 2005, 17:9-15.
37. Baerlecken N.T., Linnemann A., Gross W.L., Moosig F., Vazquez-Rodriguez T.R., Gonzalez-Gay M.A., et al. Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica. Ann Rheum Dis 2012, 71:943-947.
38. Alberts M.S., Mosen D.M. Diagnosing temporal arteritis: duplex vs. biopsy. QJM 2007, 100:785-789.
39. Breuer G.S., Nesher G., Nesher R. Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis. J Rheumatol 2009, 36:794-796.
40. Ponge T., Barrier J.H., Grolleau J.Y., Ponge A., Vlasak A.M., Cottin S. The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis. J Rheumatol 1988, 15:997-1000.
41. Breuer G.S., Nesher R., Nesher G. Effect of biopsy length on the rate of positive temporal artery biopsies. Clin Exp Rheumatol 2009, 27(Suppl.52):S10-S13.
42. Nordborg E., Bengtsson B.A., Petursdottir V., Nordborg C. Morphological aspects of giant cells in giant cell arteritis: an electron-microscopic and immunocytochemical study. Clin Exp Rheumatol 1997, 15:129-134.
43. Östberg G. Temporal arteritis in a large necropsy series. Ann Rheum Dis 1971, 30:224-235.
44. Weyand C.M., Goronzy J.J. Medium- and large-vessel vasculitis. N Engl J Med 2003, 349:160-169.
45. Makkuni D., Bharadwaj A., Wolfe K., Payne S., Hutchings A., Dasgupta B. Is intimal hyperplasia a marker of neuro-ophthalmic complications of giant cell arteritis?. Rheumatology (Oxford) 2008, 47:488-490.
46. McDonnell P.J., Moore G.W., Miller N.R., Hutchins G.M., Green W.R. Temporal arteritis. A clinicopathologic study. Ophthalmology 1986, 93:518-530.
47. Chakrabarty A., Franks A.J. Temporal artery biopsy: is there any value in examining biopsies at multiple levels. J Clin Pathol 2000, 53:131-136.
48. Chatelain D., Duhaut P., Loire R., Bosshard S., Pellet H., Piette J.C., et al. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica. Arthritis Rheum 2008, 58:2565-2573.
49. Esteban M.J., Font C., Hernández-Rodríguez J., Valls-Solé J., Sanmartí R., Cardellach F., et al. Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients. Arthritis Rheum 2001, 44:1387-1395.
50. Restuccia G., Cavazza A., Boiardi L., Pipitone N., Macchioni P., Bajocchi G., et al. Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis. Arthritis Rheum 2012, 64:549-556.
51. Karassa F.B., Matsagas M.I., Schmidt W.A., Ioannidis J.P. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med 2005, 142:359-369.
52. Schmidt W.A., Kraft H.E., Vorpahl K., Völker L., Gromnica-Ihle E.J. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997, 337:1336-1342.
53. Salvarini C., Cantini F., Boiardi L., Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002, 347:261-271.
54. Small P. Giant cell arteritis presenting as a bilateral stroke. Arthritis Rheum 1984, 27:819-821.
55. Schmidt W.A., Seifert A., Gromnica-Ihle E., Krause A., Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 2008, 47:96-101.
56. Bley T.A., Markl M., Schelp M., Uhl M., Frydrychowicz A., Vaith P., et al. Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment. Rheumatology (Oxford) 2008, 47:65-67.
57. Bley T.A., Reinhard M., Hauenstein C., Markl M., Warnatz K., Hetzel A., et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum 2008, 58:2574-2578.
58. Bley T.A., Warnatz K., Wieben O., Uhl M., Scholz C., Vaith P., et al. High-resolution MRI in giant cell arteritis with multiple inflammatory stenoses in both calves. Rheumatology (Oxford) 2005, 44:954-955.
59. Bley T.A., Wieben O., Uhl M., Thiel J., Schmidt D., Langer M. High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol 2005, 184:283-287.
60. Stanson A.W. Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol 2000, 18(Suppl.20):S43-S48.
61. López J.M., Nazabal E.R., Muñiz A.M., Rey del Corral P. Detection of posterior ischemic optic neuropathy due to giant cell arteritis with magnetic resonance imaging. Eur Neurol 2001, 46:109-110.
62. Geiger J., Ness T., Uhl M., Lagrèze W.A., Vaith P., Langer M., et al. Involvement of the ophthalmic artery in giant cell arteritis visualized by 3T MRI. Rheumatology (Oxford) 2009, 48:537-541.
63. Markl M., Uhl M., Wieben O., Ness T., Langer M., Hennig J., et al. High resolution 3T MRI for the assessment of cervical and superficial cranial arteries in giant cell arteritis. J Magn Reson Imaging 2006, 24:423-427.
64. 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2011, 38:1764-1772.
65. 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35patients. Arthritis Rheum 2006, 55:131-137.
66. 18FDG. À propos de trois observations et d'une revue de la littérature. Rev Med Interne 2002, 23:584-591.
67. Brodmann M., Lipp R.W., Passath A., Seinost G., Pabst E., Pilger E. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 2004, 43:241-242.
68. Liozon E., Monteil J., Ly K.H., Vidal E. Place de la tomographie par émission de positrons (TEP) au [18F]FDG dans l'exploration et la surveillance des vascularites. Rev Med Interne 2010, 31:417-427.
69. Bleeker-Rovers C.P., Bredie S.J.H., van der Meer J.W.M., Corstens F.H.M., Oyen W.J.G. Fluorine 18fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med 2004, 116:50-53.
70. Blockmans D., Maes A., Stroobants S., Nuyts J., Bormans G., Knockaert D., et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 1999, 38:444-447.
71. Yun M., Yeh D., Araujo L.I., Jang S., Newberg A., Alavi A. F-18FDG uptake in the large arteries: a new observation. Clin Nucl Med 2001, 26:314-319.
72. Cantini F., Salvarani C., Olivieri I., Niccoli L., Padula A., Macchioni L., et al. Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. J Rheumatol 2001, 28:1049-1055.
73. Frediani B., Falsetti P., Storri L., Bisogno S., Baldi F., Campanella V., et al. Evidence for synovitis in active polymyalgia rheumatica: sonographic study in a large series of patients. J Rheumatol 2002, 29:123-130.
74. Camellino D., Cimmino M.A. Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis. Rheumatology (Oxford) 2012, 51:77-86.
75. Cantini F., Salvarani C., Olivieri I., Niccoli L., Macchioni P., Boiardi L., et al. Inflamed shoulder structures in polymyalgia rheumatica with normal erythrocyte sedimentation rate. Arthritis Rheum 2001, 44:1155-1159.
76. Rozin A.P. US imaging of shoulder fasciitis due to polymyalgia rheumatica. Neth J Med 2008, 66:88.
77. Cantini F., Niccoli L., Nannini C., Padula A., Olivieri I., Boiardi L., et al. Inflammatory changes of hip synovial structures in polymyalgia rheumatica. Clin Exp Rheumatol 2005, 23:462-468.
78. Jiménez-Palop M., Naredo E., Humbrado L., Medina J., Uson J., Francisco F., et al. Ultrasonographic monitoring of response to therapy in polymyalgia rheumatica. Ann Rheum Dis 2010, 69:879-882.
79. Salvarani C., Barozzi L., Cantini F., Niccoli L., Boiardi L., Valentino M., et al. Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis 2008, 67:758-761.
80. Salvarani C., Cantini F., Olivieri I., Barozzi L., Macchioni L., Niccoli L., et al. Proximal bursitis in active polymyalgia rheumatica. Ann Intern Med 1997, 127:27-31.
81. Yamashita H., Kubota K., Takahashi Y., Minaminoto R., Morooka M., Ito K., et al. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. Mod Rheumatol 2012, 22:942-946.
82. Yamashita H., Kubota K., Takahashi Y., Minamimoto R., Morooka M., Kaneko H., et al. Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis. Joint Bone Spine 2012, 10.1016/j.jbspin.2012.04.006.